Prescription Solutions by OptumRx, Irvine, CA 92614, USA.
J Med Econ. 2011;14(5):562-7. doi: 10.3111/13696998.2011.598200. Epub 2011 Jul 6.
To examine medication adherence among Medicare Part D beneficiaries initiating oral anti-diabetic medications and explore whether there is any association of using mail-order pharmacy (vs. retail pharmacy) with better adherence in this patient population.
Using administrative pharmacy claims data, we conducted a retrospective cohort study on Medicare Part D beneficiaries who newly initiated oral anti-diabetic treatment between July 1, 2008 and December 31, 2008. Mail-order pharmacy users were matched to retail pharmacy users via propensity scoring, controlling for patient demographic and clinical characteristics. Adherence with oral anti-diabetic medications during the benefit year of 2009 was assessed using the proportion of days covered (PDC). Comparison of medication adherence between the mail-order pharmacy group and retail pharmacy group was conducted in the propensity matched sample using the paired t-tests and McNemar's tests.
A total of 22,546 patients who initiated oral anti-diabetic medications were identified. The average PDC was 0.60 and only 41.6% of the study population attained good adherence (defined as PDC ≥ 0.8) with oral anti-diabetic medications during calendar year 2009. The matched sample included 1361 patients in each of the mail-order and retail pharmacy cohorts. Compared with the retail pharmacy group, mail-order pharmacy users demonstrated a significantly higher PDC (0.68 vs. 0.61; P < 0.001) throughout the benefit year. More patients in the mail-order pharmacy group (49.7%) attained good adherence with their oral anti-diabetic medications compared to 42.8% in the retail pharmacy group (P < 0.001).
The study was subject to limitations inherent in retrospective claims database analysis.
Adherence with oral anti-diabetic medications among Medicare Part D beneficiaries is suboptimal. Patients using mail-order pharmacy had better adherence to oral anti-diabetic medications than those who used retail pharmacies. However, the causal relationship between mail-order pharmacy use and adherence should be further examined in a randomized study setting.
研究医疗保险处方药计划(Medicare Part D)新启用口服抗糖尿病药物的患者的用药依从性,并探讨在该患者人群中,使用邮购药房(与零售药房相比)是否与更好的依从性相关。
我们使用行政药房理赔数据,对 2008 年 7 月 1 日至 2008 年 12 月 31 日期间新启用口服抗糖尿病治疗的医疗保险处方药计划患者进行了回顾性队列研究。通过倾向评分,将邮购药房使用者与零售药房使用者进行匹配,控制患者人口统计学和临床特征。2009 年福利年度的口服抗糖尿病药物依从性通过比例天数覆盖(PDC)来评估。在倾向匹配样本中,使用配对 t 检验和 McNemar 检验比较邮购药房组和零售药房组的药物依从性。
共确定了 22546 名新启用口服抗糖尿病药物的患者。平均 PDC 为 0.60,只有 41.6%的研究人群在 2009 年的日历年内达到了良好的口服抗糖尿病药物依从性(定义为 PDC≥0.8)。匹配样本中每个邮购药房和零售药房队列包括 1361 名患者。与零售药房组相比,邮购药房使用者在整个福利年度的 PDC 显著更高(0.68 与 0.61;P<0.001)。邮购药房组(49.7%)达到良好口服抗糖尿病药物依从性的患者比例高于零售药房组(42.8%)(P<0.001)。
该研究受到回顾性理赔数据库分析固有局限性的限制。
医疗保险处方药计划患者的口服抗糖尿病药物依从性不理想。使用邮购药房的患者对口服抗糖尿病药物的依从性优于使用零售药房的患者。然而,在随机研究环境中应进一步研究邮购药房使用与依从性之间的因果关系。